Track topics on Twitter Track topics that are important to you
TxCell has raised €11M from a capital increase on Euronext Paris that will fund the company until its unique CAR-Treg technology enters the clinic. CAR-T therapy has created plenty of expectations in the field of immuno-oncology, but recent deaths in clinical ...
This awesome article First-Ever CAR-Treg Trial gets Funding Boost in France appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)
Original Article: First-Ever CAR-Treg Trial gets Funding Boost in FranceNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...